ProteinChip technology is a useful method in the pathogenesis and diagnosis of endometriosis: a preliminary study

Cleophas Kyama, Cleophas M Kyama, T'Jampens D, Davy T’Jampens, Davy T'Jampens, Attila Mihalyi, Mihalyi A, Péter Simsa, Simsa P, Peter Simsa, Sophie Debrock, Debrock S, Waelkens E, Etienne Waelkens, Landuyt B, Bart Landuyt, Meuleman C, Christel Meuleman, Vilmos Fulop, Fulop V, Vilmos Fülöp, Jason M. Mwenda, Mwenda JM, Thomas M D'Hooghe, Thomas D’Hooghe, D'Hooghe TM
Fertility and sterility · 2006 · vol. 86(1) , pp. 203–209 · doi:10.1016/j.fertnstert.2005.12.024 · PMID:16716317 · W2102695352
Other OA: bronze CC0 ⤵ 34 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This preliminary study investigated the utility of ProteinChip technology for understanding the pathogenesis and diagnosis of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To test the feasibility of ProteinChip (Ciphergen Biosystems, Inc., Fremont, CA) technology as a proteomic tool in discovering and identifying proteins that are differentially expressed in endometrium, endometriotic tissue, and normal peritoneum from women with and without endometriosis. DESIGN: Differential analysis of protein expression in women with and without endometriosis. SETTING: University hospital. PATIENT(S): A total of nine patients during their secretory phase (days 20-22) were selected for this study on the basis of cycle phase and presence/or absence of endometriosis. INTERVENTION(S): Twelve tissues used in the study included six endometrial biopsies from women with mild endometriosis (n = 3) and a normal pelvis (n = 3) as well as paired samples of peritoneal endometriotic lesions (n = 3) and macroscopically normal peritoneum biopsies (n = 3) from three women with endometriosis. MAIN OUTCOME MEASURE(S): Numerous expression differences were observed in the above comparisons, representing both up-regulation and down-regulation in protein and peptide expression levels. RESULT(S): Endometrial expression for a number of proteins and peptides in the range of 2.8-12.3 kDa was 3-24 times lower in women with endometriosis than in those without endometriosis. When compared with normal peritoneum, endometriotic lesions showed an increased expression for a set of proteins and peptides in the range of 3-96 kDa, and especially an up-regulated cluster of proteins between 22 and 23 kDa, identified to be transgelin, a smooth muscle actin-binding protein. CONCLUSION(S): This preliminary study demonstrated that differential protein profiling by using ProteinChip array technology is feasible, reproducible, and may be developed into a powerful tool for endometriosis research.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Gene Expression Profiling Protein Array Analysis Proteins Biomarkers Biomarkers Biomarkers Cells, Cultured Cells, Cultured Endometriosis Endometriosis Female Female Gene Expression Profiling Gene Expression Profiling Humans Humans Pilot Projects Pilot Projects

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (13)

Cited by (34)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:51.313027+00:00
License: CC0 · commercial use OK